Comprehensive evaluation of risk factors for the development and complications of chemotherapy-induced febrile neutropenia

Febrile neutropenia is a serious adverse effect of chemotherapy. It can lead to complications and death, as well delays in treatment, chemotherapy dose reductions, compromised treatment efficacy, reduced survival. The assessment the patient-related risk factors plays significant role prevention febrile its complications. In case intermediate-risk chemotherapy, contribute estimation an overall timely planning primary prophylaxis using growth factors. Patients presenting with undergo detailed initial for so that appropriate be selected. Recommendations given by guidelines outline classification use validated tools makes it possible optimize each patient reduce morbidity mortality due neutropenia.